# Prognosis of Cerebral Small Vessel Disease

> **NCT05734378** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 900 (estimated)

## Conditions studied

- Cerebral Amyloid Angiopathy
- Small Vessel Cerebrovascular Disease
- Cadasil
- CAA - Cerebral Amyloid Angiopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05734378
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2030-11-30
- **Final completion:** 2030-11-30
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734378, "Prognosis of Cerebral Small Vessel Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05734378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*